Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Company Analysis

ACT Insider Trading

Enact Holdings, Inc. | Insurance Agents, Brokers & Service

Comprehensive Trading Performance Summary

The investment history of corporate insiders at Enact Holdings, Inc. provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Insurance Agents, Brokers & Service sector.

Last 7 Days
$0
Buys
$214,750
Sells
Last 30 Days Trend
$0
Buys
$25,210,373
Sells

Transactions on Chart

Open Full Chart
Filing Date Trade Date Reporting Person Relationship Type Price Qty Total, $ Owned After Change, %
2021-09-20 23:13 2021-09-20 Genworth Holdings, Inc. 10% owner SELL $17.86 29,962,560 $535,131,322 132,877,440 -18.4%
2021-09-20 23:11 2021-09-20 Waleski Anne G Director BUY $19.00 5,000 $95,000 5,000 +100.0%
2021-09-20 23:10 2021-09-20 THOMPSON WESTLEY V Director BUY $19.00 5,000 $95,000 5,000 +100.0%
2021-09-20 23:10 2021-09-20 STILL DEBRA Director BUY $19.00 5,000 $95,000 5,000 +100.0%
2021-09-20 23:09 2021-09-20 Sheehan Daniel J IV Director BUY $19.00 50,000 $950,000 50,000 +100.0%
2021-09-20 23:09 2021-09-20 RESTREPO ROBERT P JR Director BUY $19.00 25,000 $475,000 25,000 +100.0%
2021-09-20 23:08 2021-09-20 Mitchell Hardin Dean Officer - EVP, CFO and Treasurer BUY $19.00 20,000 $380,000 20,000 +100.0%
2021-09-20 23:08 2021-09-20 Gupta Rohit Director, Officer - President and CEO BUY $19.00 32,000 $608,000 32,000 +100.0%
2021-09-20 23:07 2021-09-20 Gould Brian Officer - EVP & Chief Operations Officer BUY $19.00 1,000 $19,000 1,000 +100.0%
2021-09-20 23:07 2021-09-20 FISK JOHN D Director BUY $19.00 6,000 $114,000 6,000 +100.0%
2021-09-20 23:06 2021-09-20 Derstine Michael Officer - EVP and Chief Risk Officer BUY $19.00 1,000 $19,000 1,000 +100.0%
2021-09-20 23:05 2021-09-20 Addesso Dominic James Director, Other BUY $19.00 10,000 $190,000 10,000 +100.0%
2015-06-10 23:28 2015-06-09 Basgoz Nesli Director OPT+S $297.89 2,200 $655,358 4,286 0.0%
2014-12-02 01:15 2014-11-26 Meury William Officer - See Remarks OPT+S $269.14 4,550 $1,224,607 81,939 0.0%
2014-09-11 00:13 2014-09-08 PAONESSA ALBERT III Officer - President Anda, Inc. SELL $230.49 6,642 $1,530,915 21,856 -23.3%
2013-12-17 01:17 2013-12-13 BODINE CHRIS W Director SELL $159.67 3,000 $479,017 11,629 -20.5%
2013-12-11 00:55 2013-12-09 Stewart Robert A Officer - Pres-Global Operations SELL $166.02 8,000 $1,328,160 41,253 -16.2%
2013-12-10 00:32 2013-12-05 TURNER ANDREW L Director SELL $162.43 264 $42,882 0 -100.0%
2013-12-07 00:15 2013-12-06 JOYCE R TODD Officer - CFO-Global SELL $165.83 14,600 $2,421,061 40,000 -26.7%
2013-12-05 01:42 2013-12-02 TAYLOR RONALD R Director SELL $163.01 6,000 $978,060 21,942 -21.5%
2013-12-03 02:09 2013-11-27 Wilkinson George Fred Officer - PRES-ACTAVIS SPECIALTY BRANDS SELL $165.00 24,217 $3,995,805 15,412 -61.1%
2013-11-28 01:10 2013-11-26 Mayr Charles M Officer - Chief Communic Off-Global SELL $162.60 10,000 $1,626,000 11,396 -46.7%
2013-11-27 01:42 2013-11-22 TURNER ANDREW L Director SELL $163.45 2,500 $408,625 264 -90.4%
2013-11-27 01:42 2013-11-22 Wilkinson George Fred Officer - PRES-ACTAVIS SPECIALTY BRANDS SELL $165.00 5,783 $954,195 39,629 -12.7%
2013-11-20 01:35 2013-11-15 Stewart Robert A Officer - Pres-Global Operations SELL $164.44 10,000 $1,644,400 49,253 -16.9%
2013-11-19 00:30 2013-11-14 WEISS FRED G Director SELL $164.15 3,000 $492,450 24,275 -11.0%
2013-11-14 04:19 2013-11-11 BISARO PAUL Director, Officer - Chair,Pres &CEO SELL $158.73 40,921 $6,495,570 399,995 -9.3%
2013-11-14 04:19 2013-11-11 Olafsson Sigurdur O Director, Officer - PRES.-ACTAVIS PHARMA SELL $159.87 25,000 $3,996,750 71,947 -25.8%
2013-11-14 02:36 2013-11-11 BUCHEN DAVID A Officer - Chief Legal Officer-Global&Sec SELL $159.30 30,000 $4,779,000 59,966 -33.3%
2013-11-14 02:36 2013-11-11 Stewart Robert A Officer - Pres-Global Operations SELL $158.39 12,000 $1,900,680 59,252 -16.8%
2013-11-14 02:35 2013-11-11 PAONESSA ALBERT III Officer - President Anda, Inc. SELL $158.75 6,500 $1,031,875 27,229 -19.3%
2013-11-13 01:39 2013-11-07 KING JOHN A Director SELL $155.92 157,931 $24,624,775 64,647 -71.0%
2013-11-09 00:09 2013-11-06 O'Sullivan Patrick J Director SELL $157.34 3,500 $550,690 2,270 -60.7%
2013-11-09 00:09 2013-11-06 HOWSON TAMAR D Director SELL $157.34 300 $47,202 946 -24.1%
2013-11-09 00:08 2013-11-06 EBERT CHARLES D Officer - SVP, BRANDS R&D SELL $158.75 10,877 $1,726,724 7,611 -58.8%
2013-11-08 00:16 2013-11-05 JOYCE R TODD Officer - CFO-Global SELL $157.48 22,500 $3,543,300 54,600 -29.2%
2013-11-07 00:24 2013-11-04 TURNER ANDREW L Director SELL $156.48 2,677 $418,893 2,764 -49.2%
2013-11-06 01:27 2013-11-04 Eagan Patrick Officer - CHIEF HR OFFICER-GLOBAL SELL $156.71 7,200 $1,128,331 7,009 -50.7%
2013-09-19 01:17 2013-09-16 HUMMEL ALBERT F Director SELL $137.81 6,200 $854,397 82,776 -7.0%
2013-09-06 23:05 2013-09-04 Wilkinson George Fred Officer - Pres-Global Brands&Biosimilars SELL $138.00 16,749 $2,311,362 52,469 -24.2%
2013-09-06 23:02 2013-09-04 MICHELSON JACK Director SELL $139.54 6,064 $846,163 1,877 -76.4%
2013-09-04 01:07 2013-08-29 BUCHEN DAVID A Officer - Chief Legal Officer-Global&Sec OPT+S $135.56 10,000 $1,355,579 97,373 0.0%
2013-08-27 00:07 2013-08-22 HUMMEL ALBERT F Director SELL $134.44 40,000 $5,377,616 92,776 -30.1%
2013-08-22 23:27 2013-08-20 BISARO PAUL Director, Officer - President & CEO SELL $135.30 50,000 $6,765,090 469,232 -9.6%
2013-08-19 23:10 2013-08-15 PAONESSA ALBERT III Officer - President of Anda, Inc. SELL $135.89 5,476 $744,113 33,812 -13.9%
2013-08-15 23:47 2013-08-13 HUMMEL ALBERT F Director OPT+S $133.85 10,000 $1,338,525 132,776 0.0%
2013-08-15 23:46 2013-08-14 JOYCE R TODD Officer - CFO-Global SELL $137.98 15,000 $2,069,750 80,470 -15.7%
2013-08-15 00:41 2013-08-12 Mayr Charles M Officer - Chief Communic Off-Global SELL $133.23 4,820 $642,166 23,490 -17.0%
2013-08-15 00:29 2013-08-12 KLEMA CATHY Director SELL $133.03 1,667 $221,767 19,608 -7.8%
2013-08-14 01:13 2013-08-05 EBERT CHARLES D Officer - Sr. VP, Research & Development SELL $136.25 8,244 $1,123,246 19,970 -29.2%
SHOW ENTRIES
51-100 OF 110

How to Interpret $ACT Trades

Not every insider transaction in Enact Holdings, Inc. is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $ACT shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.

Data Source & Accuracy for ACT

Insider activity data for Enact Holdings, Inc. is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $ACT, allowing you to follow the capital of those with the most intimate knowledge of the company.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.